Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
3.060
+0.170 (5.88%)
At close: Mar 9, 2026, 4:00 PM EDT
2.933
-0.127 (-4.16%)
After-hours: Mar 9, 2026, 7:09 PM EDT

Dogwood Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-38.2-12.35-5.3-12.25-15.96-10.35
Depreciation & Amortization
0.010.01----
Stock-Based Compensation
0.290.480.620.580.327.43
Other Adjustments
9.573.65----0
Changes in Accounts Payable
-0.770.22-0.460.220.270.05
Changes in Accrued Expenses
-0.63-0.3-0.22-0.45-0.230.63
Changes in Other Operating Activities
-0.93-0.50.490.43-0.09-1.66
Operating Cash Flow
-18.11-8.79-4.87-11.47-15.69-3.9
Other Investing Activities
-3.76----
Investing Cash Flow
-3.76----
Long-Term Debt Issued
18.3215.32---1.99
Net Long-Term Debt Issued (Repaid)
18.3215.32---1.99
Issuance of Common Stock
4.221.381.164.49-0.131.53
Net Common Stock Issued (Repurchased)
4.221.381.164.49-0.131.53
Other Financing Activities
--0----0.14
Financing Cash Flow
22.5716.71.164.49-0.133.38
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.14-0.14----
Net Cash Flow
8.2211.68-3.71-6.98-15.7929.49
Free Cash Flow
-18.11-8.79-4.87-11.47-15.69-3.9
Free Cash Flow Per Share
-11.01-8.55-6.48-25.90-47.09-19.76
Levered Free Cash Flow
-20.442.92-5.49-12.05-16.01-9.33
Unlevered Free Cash Flow
-33.87-12.8-5.64-12.12-15.69-10.98
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q